Gene · 10332
Papers1,514
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,514
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Corrigendum] CLEC4M overexpression inhibits progression and is associated with a favorable prognosis in hepatocellular carcinoma. | Mol Med Rep | 2026 | 42695409 | PubTator, text mining | PubMed |
| Whole genome sequencing to elucidate novel genetic modifiers of FVIII clearance. | Blood | 2026 | 42636151 | PubTator, text mining | PubMed |
| Integrating Bulk and Single-Cell RNA Sequencing to Identify Prognostic Genes Associated with Adaptive Immunity and the Tumor Microenvironment in Cholangiocarcinoma for Risk Model Construction. | Immunobiology | 2026 | 42468280 | PubTator, text mining | PubMed |
| Exploring SNPs in viral entry-related protein genes and their association with severe fever with thrombocytopenia syndrome virus infection risk. | Microbiol Spectr | 2026 | 42454931 | PubTator, text mining | PubMed |
| AI-Driven Discovery of Prototype CLEC4M Inhibitors Targeting Marburg Virus Entry via Integrated Machine Learning and Molecular Modeling. | Int J Mol Sci | 2026 | 42353044 | PubTator, text mining | PubMed |
| Chronic military stress and glandular epithelial tumor biology: an integrative neuroendocrine-inflammatory framework with insights from microgravity gene discovery. | Front Oncol | 2026 | 42344694 | PubTator, text mining | PubMed |
| Pathogenicity of Rift Valley fever virus: Organ-specific clinical outcomes and hidden drivers of virulence - a narrative review. | Virulence | 2026 | 41928558 | PubTator, text mining | PubMed |
| From a Multi-Omics Signature to a Therapeutic Candidate: Computational Prediction and Experimental Validation in Liver Fibrosis. | Pharmaceuticals (Basel) | 2026 | 41901341 | PubTator, text mining | PubMed |
| Immunoregulatory effect of metformin in monocytes exposed to SARS-CoV-2 spike protein subunit 1. | Immunometabolism (Cobham) | 2026 | 41768486 | PubTator, text mining | PubMed |
| Glycosylated carbon nanodots as multivalent blockers of lectin-driven viral entry: structural insights and antiviral performance. | Nanoscale | 2026 | 41757861 | PubTator, text mining | PubMed |
| A Cryptic Pocket Allosterically Modulates Oligosaccharide Binding to DC-SIGN. | JACS Au | 2026 | 41755834 | PubTator, text mining | PubMed |
| Sub-neutralizing concentrations of Zika virus IgM monoclonal antibodies reduce IgG-mediated antibody-dependent enhancement of infectivity. | bioRxiv | 2026 | 41743987 | PubTator, text mining | PubMed |
| Association between LDL-R (exon 8 C.1171 G > A) polymorphisms and response to antiviral therapy in hepatitis C virus infection. | Sci Rep | 2026 | 41720870 | PubTator, text mining | PubMed |
| Plasma Proteomic Signatures of Physical Activity Provide Insights into Biological Impacts and its Protective Role against Dementia. | Med Sci Sports Exerc | 2026 | 41582318 | PubTator, text mining | PubMed |
| West Nile virus: epidemiology, prevention, clinical features, diagnosis, treatment, and open research questions. | Ann Med | 2026 | 41546488 | PubTator, text mining | PubMed |
| Molecular and biophysical requirements for B cell receptor dependent enhancement of dengue virus infection. | bioRxiv | 2026 | 41542475 | PubTator, text mining | PubMed |
| ACE2-independent entry factors for SARS-CoV-2 infection and immune activation. | mBio | 2026 | 41427721 | PubTator, text mining | PubMed |
| Complex genetic effects linked to plasma protein abundance in the UK Biobank. | Nat Commun | 2025 | 41392155 | PubTator, text mining | PubMed |
| Cellular and molecular keys to entry: Mechanisms mediating Orthoflavivirus infection of the mosquito midgut. | PLoS Pathog | 2025 | 41144442 | PubTator, text mining | PubMed |
| Increasing the Chemical Space of L-SIGN Specific Glycomimetics. | J Med Chem | 2025 | 41108276 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10332/papers